Literature DB >> 1675330

Identification of the causes of persistent hyperuricaemia.

B T Emmerson1.   

Abstract

Accurate identification of the factors that contribute to hyperuricaemia in an individual may enable some of these factors to be modified, and lead to permanent correction of the hyperuricaemia. A protocol is described which can supplement clinical assessment. Measurement of the effects on serum urate and urinary urate excretion of a low-purine diet for 7 days facilitates the identification of the contributions made by urate production (either endogenous or from purine consumption) and renal underexcretion of urate (either as a low urate clearance in the absence of renal disease or due to renal glomerular insufficiency).

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1675330     DOI: 10.1016/0140-6736(91)93141-u

Source DB:  PubMed          Journal:  Lancet        ISSN: 0140-6736            Impact factor:   79.321


  12 in total

Review 1.  Hyperuricemia and renal function.

Authors:  L M Ruilope; J Garcia-Puig
Journal:  Curr Hypertens Rep       Date:  2001-06       Impact factor: 5.369

Review 2.  Diagnosis and management of gout: a rational approach.

Authors:  E Suresh
Journal:  Postgrad Med J       Date:  2005-09       Impact factor: 2.401

3.  Hyperlipidaemia in hyperuricaemia and gout.

Authors:  B Emmerson
Journal:  Ann Rheum Dis       Date:  1998-09       Impact factor: 19.103

4.  Identification of 8-aminoadenosine derivatives as a new class of human concentrative nucleoside transporter 2 inhibitors.

Authors:  Kazuya Tatani; Masahiro Hiratochi; Yoshinori Nonaka; Masayuki Isaji; Satoshi Shuto
Journal:  ACS Med Chem Lett       Date:  2015-01-28       Impact factor: 4.345

5.  Decreased triglyceride levels with low calorie diet and increased renal excretion of uric acid in hyperuricaemic-hyperlipidaemic patients.

Authors:  F J Tinahones; F J Soriguer; E Collantes; G Pérez-Lindón; P Sánchez Guijo; J A Lillo
Journal:  Ann Rheum Dis       Date:  1995-07       Impact factor: 19.103

Review 6.  Clinical and biochemical aspects of uric acid overproduction.

Authors:  J García Puig; F A Mateos
Journal:  Pharm World Sci       Date:  1994-04-15

7.  Variability of lipid phenotypes in hyperuricaemic-hyperlipidemic patients.

Authors:  E Collantes; F J Tinahones; A Cisnal; J Añon; P Sanchez-Guijo
Journal:  Clin Rheumatol       Date:  1994-06       Impact factor: 2.980

8.  Individualized treatment strategies for hyperuricemia informed by a semi-mechanistic exposure-response model of uric acid dynamics.

Authors:  Sergey Aksenov; Carl C Peck; Ulf G Eriksson; Donald R Stanski
Journal:  Physiol Rep       Date:  2018-03

Review 9.  Formate metabolism in health and disease.

Authors:  Matthias Pietzke; Johannes Meiser; Alexei Vazquez
Journal:  Mol Metab       Date:  2019-07-30       Impact factor: 7.422

10.  EGCG Attenuates Uric Acid-Induced Inflammatory and Oxidative Stress Responses by Medicating the NOTCH Pathway.

Authors:  Hua Xie; Jianqin Sun; Yanqiu Chen; Min Zong; Shijie Li; Yan Wang
Journal:  Oxid Med Cell Longev       Date:  2015-10-11       Impact factor: 6.543

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.